金融股捱沽拖累恒指倒跌 友邦(01299.HK)吐4%
季绩後获多间大行维持正面看法的友邦保险(01299.HK)继昨天续升至90元创纪录高遇阻打回原形後,今天股价回吐4%报83.5元,成交2,521万股,涉资21.53亿元。
友邦本周一公布,今年第三季新业务价值按固定汇率计算按年跌28%至7.06亿美元,但按季升22%。高盛指,友邦上季新业务价值优於该行预测6.7亿美元,主要受惠年化新保费按季强劲升24%推动,故维持友邦「确信买入」名单及目标价85元。大摩季绩後也维持友邦「增持」评级及目标价为87元,以反映新业务价值符预期及业务明显较上半年改善。
市场权衡疫苗研发露曙光和新增确诊病例激增及经济反弹可能时机,资金重新由旧经济股转投科技股,拖累道指昨晚逆市回软。港股也不例外,恒指昨天反覆回软结束四连涨後,今早在三大科技股急弹推动高开0.7%报26,409,最高见26,460遇阻,在汇控(00005.HK)、恒生(00011.HK)、三大蓝筹国有行工行(01398.HK)、建行(00939.HK)、中行(03988.HK)及中银(02388.HK)及友邦挫逾1.5%-3.5%拖累下,曾低见26,137,现造26,199,续吐27点或0.1%,成交额765亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.